Setting 
My Cart
Toggle Nav
mobile icon
Close
  • Menu
  • Setting

Signaling Pathways

Items 81-90 of 9364

Page
per page
  1. Topotecan HCl
    B2296 Topotecan HCl
     2 Citation
    Summary: Topoisomerase 1 inhibitor
      ≥22.9 mg/mL
  2. DMH-1
    B3686 DMH-1
     2 Citation
    Target: BMP and Other Activin Receptors
    Summary: Selective BMP ALK2 receptor
      insoluble in H2O; insoluble in EtOH; ≥9.51 mg/mL
  3. Midostaurin (PKC412)
    B3709 Midostaurin (PKC412)
     1 Citation
    Target: PKC|PKA|KDR|Flk1|PPK|c-Syk|CDK1/CyclinB
    Summary: PKC inhibitor
      ≥57.1 mg/mL
  4. Chlorambucil
    B3716 Chlorambucil
    Summary: nitrogen mustard alkylating agent
      insoluble in H2O; ≥12.15 mg/mL
  5. T-5224
    B4664 T-5224
     10 Citation
    Target: AP-1|MMP
    Summary: C-Fos/AP-1 inhibitor
      ≥25.88 mg/mL
  6. Bromocriptine mesylate
    B6298 Bromocriptine mesylate
    Summary: A potent, selective D2-like dopamine receptor agonist
      insoluble in H2O; insoluble in EtOH; ≥20.05 mg/mL
  7. POM 1
    B7153 POM 1
    Summary: A potent Ecto-NTPDase inhibitor
      ≥149.3 mg/mL
  8. Withaferin A
    B7199 Withaferin A
     2 Citation
    Summary: Prevents NF-κB activation by inhibiting activation of IKKβ
      Soluble in DMSO
  9. Sulprostone
    B7255 Sulprostone
    Summary: EP3 and EP1 receptor agonist
  10. Sodium acetate
    B7296 Sodium acetate
    Summary: Commonly used laboratory reagent
      ≥8.2 mg/mL

Items 81-90 of 9364

Page
per page